The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstWest Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE: WST)forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg

Investors who purchased the Company's securities between February 16, 2023 and February 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 7, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website atwww.schallfirm.com, or by email atbschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. West claimed to have strong visibility into customer demand, but suffered from significant destocking of its High-Value Products portfolio. The Company's SmartDose device, purportedly a high-margin product, was in fact dilutive of its profit margins due to inefficiencies. The Company suffered margin pressures increasing the risk of restructuring such as exiting continuous glucose monitoring contacts with long-term customers. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about West, investors suffered damages.

Join the caseto recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law FirmBrian Schall, Esq.,www.schallfirm.comOffice: 310-301-3335info@schallfirm.com

https://c212.net/c/img/favicon.png?sn=LA24602&sd=2025-07-07

View original content to download multimedia:https://www.prnewswire.com/news-releases/wst-investors-have-opportunity-to-lead-west-pharmaceutical-services-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302498518.html

SOURCE The Schall Law Firm

https://rt.newswire.ca/rt.gif?NewsItemId=LA24602&Transmission_Id=202507070950PR_NEWS_USPR_____LA24602&DateId=20250707

COMTEX_467061479/1005/2025-07-07T09:50:14